Clinical Trial

Prevention of Postpartum Hemorrhage with TXA

Study Description

Prevention of Postpartum Hemorrhage With TXA

Hemorrhage remains the leading cause of maternal death worldwide. Tranexamic acid has been shown to reduce rates of hemorrhage when given prophylactically prior to cesarean delivery. It has also been shown to be an effective treatment in response to hemorrhage after a vaginal delivery. The aim of this study is to assess the impact of TXA on hemorrhage rates when given prophylactically prior to all deliveries.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - Tranexamic Acid 1000 mg/10ml normal saline infusion

Infusion of Tranexamic Acid (Cyklokapron) to all consented women with the delivery of the anterior shoulder of the infant

Additional Information

Official Study Title

Prevention of Postpartum Hemorrhage With Tranexamic Acid (TXA)

Clinical Trial ID

NCT03326596

ParticipAid ID

1aKpzb